Gyre Therapeutics (GYRE) Property, Plant & Equipment (Net) Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -14.40% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -9.89% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 10.71% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -0.31% |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | 2,767.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,767.25% |
| Dec 31, 2025 | 10.04% |
| Sep 30, 2025 | 475.28% |
| Jun 30, 2025 | 422.55% |
| Mar 31, 2025 | 201.63% |
| Dec 31, 2024 | 190.91% |
| Sep 30, 2024 | 181.91% |
| Jun 30, 2024 | 225.88% |
| Mar 31, 2024 | 295.12% |
| Dec 31, 2023 | 277.47% |
| Mar 31, 2023 | -84.99% |
| Dec 31, 2022 | 287.65% |
| Sep 30, 2022 | -28.48% |
| Jun 30, 2022 | -23.82% |
| Mar 31, 2022 | 34.02% |
| Dec 31, 2021 | 35.95% |
| Sep 30, 2021 | 62.34% |
| Jun 30, 2021 | 32.96% |
| Mar 31, 2021 | 5.53% |
| Dec 31, 2020 | 16.20% |
| Sep 30, 2020 | 11.70% |
| Jun 30, 2020 | 10.35% |
| Mar 31, 2020 | -9.47% |
| Dec 31, 2019 | -11.86% |
| Sep 30, 2019 | -22.06% |
| Jun 30, 2019 | -22.69% |
| Mar 31, 2019 | -19.48% |
| Dec 31, 2018 | -17.92% |
| Sep 30, 2018 | -28.88% |
| Jun 30, 2018 | 25.00% |
| Mar 31, 2018 | -4.49% |
| Dec 31, 2017 | -32.84% |
| Sep 30, 2017 | -13.28% |
| Jun 30, 2017 | -12.86% |
| Mar 31, 2017 | -13.24% |
| Dec 31, 2016 | -13.33% |
| Sep 30, 2016 | -1.45% |
| Jun 30, 2016 | -5.25% |
| Mar 31, 2016 | -23.12% |
| Dec 31, 2015 | -24.76% |
| Dec 31, 2014 | -43.44% |